“This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low- and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic,” Charles Gore, Executive Director of MPP, said in a statement.
Pfizer agrees to let other companies produce its anti-viral COVID-19 pill, making it available in low-income countries
Prepare Now Before its too Late
Discover where products are available & compare prices
